AGENUS (AGEN) Reports In-Line Q3 EPS, Sales Fall Short of Expectations
Tweet
Share
E-mailGet Alerts AGEN Hot Sheet
Price: $8.24 --0%
Financial Fact:
Research and development: -21.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Research and development: -21.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
AGENUS (NASDAQ: AGEN) reported Q3 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $654 thousand versus the consensus estimate of $720 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
